Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID Reference, 4th edition, 372 pages

+ the daily Top 10

  Prostate Cancer

  Free Subscription

Articles published in Am J Pathol

Retrieve available abstracts of 14 articles:
HTML format

Single Articles

    August 2020
  1. CHUNG WC, Zhou X, Atfi A, Xu K, et al
    Pik3cg is a potential therapeutic target in androgen receptor-indifferent metastatic prostate cancer.
    Am J Pathol. 2020 Aug 14. pii: S0002-9440(20)30371.
    PubMed     Abstract available

    November 2019
  2. PORTER CM, Haffner MC, Kulac I, Maynard JP, et al
    Lactoferrin CpG Island Hypermethylation and Decoupling of mRNA and Protein Expression in the Early Stages of Prostate Carcinogenesis.
    Am J Pathol. 2019;189:2311-2322.
    PubMed     Abstract available

    September 2019
  3. LAURSEN EB, Fredsoe J, Schmidt L, Strand S, et al
    Elevated miR-615-3p expression predicts adverse clinical outcome and promotes proliferation and migration of prostate cancer cells.
    Am J Pathol. 2019 Sep 17. pii: S0002-9440(19)30711.
    PubMed     Abstract available

    August 2019
  4. RANI A, Dasgupta P, Murphy JJ
    Prostate Cancer- The Role of Inflammation and Chemokines.
    Am J Pathol. 2019 Aug 14. pii: S0002-9440(19)30663.
    PubMed     Abstract available

    June 2019
  5. DANKNER M, Ouellet V, Communal L, Schmitt E, et al
    CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis.
    Am J Pathol. 2019 Jun 11. pii: S0002-9440(18)31099.
    PubMed     Abstract available

  6. FIGIEL S, Pasqualin C, Bery F, Maupoil V, et al
    Functional Organotypic Cultures of Prostate Tissues: A Relevant Preclinical Model that Preserves Hypoxia Sensitivity and Calcium Signaling.
    Am J Pathol. 2019;189:1268-1275.
    PubMed     Abstract available

    May 2019
  7. HWANG MJ, Bryant KG, Seo JH, Liu Q, et al
    Syntaphilin Is a Novel Biphasic Biomarker of Aggressive Prostate Cancer and a Metastasis Predictor.
    Am J Pathol. 2019 May 3. pii: S0002-9440(18)30742.
    PubMed     Abstract available

    March 2019
  8. VELLKY JE, Ricke EA, Huang W, Ricke WA, et al
    Expression and Localization of DDX3 in Prostate Cancer Progression and Metastasis.
    Am J Pathol. 2019 Mar 26. pii: S0002-9440(18)30965.
    PubMed     Abstract available

    January 2019
  9. BAUMANN B, Acosta AM, Richards Z, Deaton R, et al
    High miR-182 Levels Associate with Low-Risk Prostate Cancer.
    Am J Pathol. 2019 Jan 28. pii: S0002-9440(18)30384.
    PubMed     Abstract available

    September 2018
  10. HUHTANIEMI R, Oksala R, Knuuttila M, Mehmood A, et al
    Adrenals Contribute to Growth of Castration-Resistant VCaP Prostate Cancer Xenografts.
    Am J Pathol. 2018 Sep 28. pii: S0002-9440(18)30499.
    PubMed     Abstract available

    March 2018
  11. HAFFNER MC, Guner G, Taheri D, Netto GJ, et al
    Comprehensive evaluation of PD-L1 expression in primary and metastatic prostate cancer.
    Am J Pathol. 2018 Mar 22. pii: S0002-9440(17)31179.
    PubMed     Abstract available

    January 2018
  12. GONNISSEN A, Isebaert S, Perneel C, McKee CM, et al
    Patched 1 Expression Correlates with Biochemical Relapse in High-Risk Prostate Cancer Patients.
    Am J Pathol. 2018 Jan 12. pii: S0002-9440(17)30378.
    PubMed     Abstract available

    November 2017
  13. KNUUTTILA M, Mehmood A, Huhtaniemi R, Yatkin E, et al
    Antiandrogens Reduce Intratumoral Androgen Concentrations and Induce Androgen Receptor Expression in Castration-Resistant Prostate Cancer Xenografts.
    Am J Pathol. 2017 Nov 7. pii: S0002-9440(17)30537.
    PubMed     Abstract available

  14. LATONEN L, Scaravilli M, Gillen A, Hartikainen S, et al
    In Vivo Expression of miR-32 Induces Proliferation in Prostate Epithelium.
    Am J Pathol. 2017;187:2546-2557.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Prostate Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.